A Phase I Clinical Study of MK0683 in Patients With Solid Tumors.

Trial Profile

A Phase I Clinical Study of MK0683 in Patients With Solid Tumors.

Completed
Phase of Trial: Phase I

Latest Information Update: 14 Mar 2013

At a glance

  • Drugs Vorinostat (Primary)
  • Indications Solid tumours
  • Focus Adverse reactions
  • Most Recent Events

    • 20 Dec 2011 Actual end date (Aug 2009) added as reported by ClinicalTrials.gov.
    • 18 Sep 2008 Additional trial identifier MK0683-029 as reported by ClinicalTrials.gov.
    • 18 Sep 2008 Planned patient number (21) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top